A Dose-response Study of Dietary Resveratrol on Lipid Metabolism Disorder

• Status: Recruiting
• Trial end date: 2022-12-30
• Target enrollment: 0
• Participant gender: All

Summary

In order to study the effect of resveratrol on the improvement of lipid metabolism, randomized intervention trials were conducted to compare the effects of resveratrol on the improvement of lipid metabolism in different dose groups. To explore the best dose of resveratrol for the prevention and treatment of metabolic diseases provide an important scientific basis.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Sun Yat-sen University
• Treatments: Resveratrol

Criteria

Inclusion Criteria:

• Dyslipidemia

• The age between 35 and 70 years old

Exclusion Criteria:

• Intake of any medicine that affect lipid metabolism currently or in the preceding 6 months

• Dietary supplementation with phytochemicals including resveratrol in the preceding 3 months

• History of acute or chronic infectious disease, autoimmune disease, cancer, traumatic injury, or surgery in the preceding 1 month

• History of severe chronic disease including AS and CVD, liver or renal dysfunction, and lactation or pregnancy

• Pregnant woman and Breast Feeding Women